Zenas BioPharma, Inc. - ZBIO
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 22
Latest filed: Oct 13, 2026
| Form | Count |
|---|---|
| 4 | 13 |
| 8-K | 3 |
| SCHEDULE 13D/A | 2 |
| SCHEDULE 13G | 1 |
| SCHEDULE 13G/A | 1 |
| 144 | 1 |
| SCHEDULE 13D | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Oct 13, 2026 | 8-K | Oct 12, 2026 | 0001104659-26-115151 | View |
| Sep 08, 2026 | SCHEDULE 13G | — | 0000902219-26-000315 | View |
| Sep 08, 2026 | SCHEDULE 13G/A | — | 0001213900-26-097825 | View |
| Sep 02, 2026 | 4 | Sep 01, 2026 | 0001104659-26-104728 | View |
| Aug 19, 2026 | SCHEDULE 13D/A | — | 0001953107-26-000015 | View |
| Aug 19, 2026 | 144 | — | 0001968582-26-000858 | View |
| Aug 17, 2026 | SCHEDULE 13D/A | — | 0001072613-26-000694 | View |
| Aug 13, 2026 | 8-K | Aug 12, 2026 | 0001104659-26-095437 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075249 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075250 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075251 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075252 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075253 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075254 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075255 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075256 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001104659-26-075257 | View |
| Jun 17, 2026 | 4 | Jun 15, 2026 | 0001193125-26-274473 | View |
| May 18, 2026 | 4 | May 18, 2026 | 0001104659-26-063362 | View |
| May 13, 2026 | 8-K | May 11, 2026 | 0001104659-26-059700 | View |
| May 05, 2026 | SCHEDULE 13D | — | 0001104659-26-055643 | View |
| Apr 29, 2026 | 4 | Apr 28, 2026 | 0001104659-26-051889 | View |